Meeting
2016 ASCO Annual Meeting
Suggested reclassification strategy applied to intermediate and poor risk nonseminomatous germ cell tumors (NSGCT): A two-institution combined analysis.
Authors
Andrea Necchi
Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Andrea Necchi , Gregory Russell Pond , Nicola Nicolai , Nabil Adra , Patrizia Giannatempo , Daniele Raggi , Nasser H. Hanna , Roberto Salvioni , Lawrence H. Einhorn , Costantine Albany
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Germ Cell/Testicular
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4546)
DOI
10.1200/JCO.2016.34.15_suppl.4546
Abstract #
4546
Poster Bd #
168
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Prognostic significance of raised serum tumor markers (STM) after 2 cycles of chemotherapy in men with intermediate- and poor-risk non-seminomatous testicular germ cell tumors (NSGCT) treated at a single-centre in India.
First Author: ANKUR NANDAN VARSHNEY
Poster
2012 Genitourinary Cancers Symposium
Association of GSTP1, COMT, and TPMT with testicular cancer (TC) treatment outcome after cisplatin-based chemotherapy (CBCT).
First Author: Chunkit Fung
Poster
2020 Genitourinary Cancers Symposium
Development of a risk calculator of recurrence in inguinal lymph node metastatic (ILNM) patients with surgically resected penile squamous cell carcinoma (PSCC).
First Author: Marco Bandini
Poster
2015 ASCO Annual Meeting
Perioperative morbidity and mortality with bleomycin in primary mediastinal non seminomatous germ cell tumor (PMNSGCT).
First Author: Praveen Ranganath